From Global Elimination to National Control: the Rubella Epidemic Situation in the World and the Russian Federation
https://doi.org/10.31631/2073-3046-2025-24-6-106-116
Abstract
Relevance. Rubella remains a significant public health concern despite substantial progress in its elimination in many countries worldwide. Disruptions to routine immunization programs during the COVID-19 pandemic, uneven vaccination coverage in certain regions, and the presence of population groups create conditions for the continued risk of importation, localized outbreaks, and the occurrence of congenital rubella syndrome.
Aim. To analyze the current epidemiological situation of rubella worldwide and in the Russian Federation, assess trends in incidence and vaccination coverage, and review key approaches to vaccination strategies and maintenance of elimination status.
Conclusion. The analysis demonstrates persistent heterogeneity in the epidemiological situation of rubella across different regions of the world despite an overall decline in incidence. Even in countries that have achieved elimination, the risk of renewed transmission persists in the presence of unvaccinated cohorts and population groups at increased risk. Maintaining elimination status requires high vaccination coverage, effective epidemiological surveillance, and the implementation of catch-up immunization campaigns, with particular emphasis on the prevention of congenital rubella syndrome.
About the Author
L. A. Barkinkhoeva
G. N. Gabrichevsky Research Institute for Epidemiology and Microbiology
Russian Federation
Russian Federation
Barkinkhoeva Laura A., researcher at the Research Center for the Study of Viral Airborne Infections
10, Admiral Makarov str., Moscow, 125212
+7 (985) 626-25-19
References
1. Centers for Disease Control and Prevention (CDC). Rubella [Internet]. In: Surveillance Manual. Chapter 14. Atlanta: CDC; 2024 [cited 2025 Oct 20]. Available at: https://www.cdc.gov/surv-manual/php/table-of-contents/chapter-14-rubella.html
2. Lambert N, Strebel P, Orenstein W, Icenogle J. Review of congenital rubella syndrome and rubella infection. Infect Dis Clin North Am. 2022;36(1):35–47.
3. World Health Organization. Rubella and congenital rubella syndrome: Key facts [Internet]. Geneva: WHO; 2024 [cited 2025 Oct 22]. Available at: https://www.who.int/newsroom/fact-sheets/detail/rubella
4. Gastañaduy PA, Budd J, Fisher-Hoch S, et al. Rubella elimination: lessons learned and next steps. Vaccine. 2023;41(7):1531–1542.
5. World Health Organization. Measles and Rubella Strategic Framework 2021–2030 [Internet]. Geneva: WHO; 2021 [cited 2025 Oct 22]. Available at: https://www.who.int/publications/i/item/measles-and-rubella-strategic-framework-2021-2030
6. UNICEF/WUENIC. Global Immunization Coverage Estimates [Internet]. 2024 [cited 2025 Oct 22]. Available at: https://data.unicef.org/wp-content/uploads/2025/07/WUENIC_notes_for_AllCountries_2024rev.pdf
7. World Health Organization. Rubella Elimination Progress Report, African Region [Internet]. 2024 [cited 2025 Oct 22]. Available at: https://immunizationdata.who.int/dashboard/regions/african-region
8. World Health Organization, South-East Asia Region. Rubella surveillance and vaccination data [Internet]. 2025 [cited 2025 Oct 22]. Available at: https://www.who.int/southeastasia/activities/measles-and-rubella-elimination
9. Moss WJ, Griffin DE. Global progress toward rubella elimination. Lancet Infect Dis. 2023;23(4):452–460.
10. Winter AK, Moss WJ. Rubella. Lancet. 2022;399(10332):1336–1346. doi:10.1016/S0140-6736(21)02691-X
11. CDC. Global Burden of Rubella and Congenital Rubella Syndrome, 2025. MMWR Morb Mortal Wkly Rep. 2025;74(12):105–113.
12. Pan American Health Organization (PAHO). Rubella and CRS elimination status update [Internet]. Washington, DC: PAHO; 2024 [cited 2025 Oct 22]. Available at: https://www.paho.org/en/topics/rubella
13. World Health Organization (WHO). Global Rubella Elimination Initiative: Progress Report 2025 [Internet]. Geneva: WHO; 2025 [cited 2025 Oct 22]. Available at: https://www.who.int/publications/search?query=Global+Rubella+Elimination+Initiative+2025
14. Kinoshita R, Arai S, Suzuki M, Nishiura H. Identifying the population susceptible to rubella in Japan, 2020: Fine-scale risk mapping. J Infect Public Health. 2024;17(5):1023– 1030. doi:10.1016/j.jiph.2024.03.029
15. Zimmerman LA, Knapp JK, Antoni S, Grant GB, Reef SE. Progress toward rubella and congenital rubella syndrome control and elimination—worldwide, 2012-2020. MMWR Morb Mortal Wkly Rep. 2022;71(6):196–201. doi:10.15585/mmwr.mm7106a2
16. European Centre for Disease Prevention and Control (ECDC). Measles and Rubella Monitoring Report [Internet]. Stockholm: ECDC; 2025 [cited 2025 Oct 22]. Available at: https://www.ecdc.europa.eu/en/publications-data/measles-and-rubella-monitoring-report-2025
17. Knapp JK, Mariano KM, Pastore R, Grabovac V, Takashima Y, Alexander JP Jr, et al. Progress toward rubella elimination—Western Pacific Region, 2000-2019. MMWR Morb Mortal Wkly Rep. 2020;69(24):744–750. doi:10.15585/mmwr.mm6924a4
18. ECDC. Rubella and CRS surveillance data in EU/EEA [Internet]. 2024 [cited 2025 Oct 22]. Available at: https://www.ecdc.europa.eu/en/rubella-crs-surveillance-dataeu-eea
19. Ministry of Health of the Russian Federation. National Immunization Schedule [Internet]. Moscow: Ministry of Health; 2025 [cited 2025 Oct 22]. Available at: https://msch59.ru/wp-content/uploads/2025/05/20-nacionalnyj_kalendar_profilakticheskih_privivok_compressed.pdf
20. Kharit SM, Melnikova IN, Cherkasskaya OV. Epidemiological aspects of rubella surveillance in the post-elimination period. Epidemiology and Vaccinal Prevention. 2023;22(3):45–52.
21. Rozhkova LY, Uskov AN. Current issues of measles and rubella vaccination in Russia. Epidemiology and Vaccinal Prevention. 2024;23(1):17–25.
22. Rospotrebnadzor. Results of epidemiological surveillance of rubella in the Russian Federation in 2024. Moscow; 2025.
23. Pimenov NV, Drozdova IV. Analysis of coverage with preventive vaccinations against measles and rubella in the Russian Federation. Infectious Diseases: News, Opinions, Training. 2023;12(2):41–48.
24. Cherkasskaya OV, Kozlova NA. Features of seroepidemiological monitoring of population immunity to rubella virus. Journal of Microbiology, Epidemiology and Immunobiology. 2022;99(4):72–80.
25. Uskov AN, Rozhkova LY. Rubella surveillance in Russia during the COVID-19 pandemic. Epidemiology and Vaccinal Prevention. 2022;21(4):23–31.
26. Muscat M, et al. Maintaining measles and rubella elimination in the European Region. Vaccine. 2024;42(5):812–819.
27. World Health Organization. Guidance on post-pandemic recovery of routine immunization services. Geneva: WHO; 2023.
28. Kaminska A, Plata-Nazar K. Mandatory childhood vaccinations in Poland–The art of preventing the preventable. Vaccines. 2022;10(11):1–14. doi:10.3390/vaccines10111806
29. Ujiie M. Rubella resurgence in Japan, 2018-2019. J Travel Med. 2019;26(6):taz047. doi:10.1093/jtm/taz047
30. World Health Organization. Child mortality (under 5 years) [Internet]. [cited 2023 Oct 8]. Available at: https://www.who.int/news-room/fact-sheets/detail/levels-andtrends-in-child-under-5-mortality-in-2020
Review
For citations:
Barkinkhoeva L.A. From Global Elimination to National Control: the Rubella Epidemic Situation in the World and the Russian Federation. Epidemiology and Vaccinal Prevention. 2025;24(6):106-116. (In Russ.) https://doi.org/10.31631/2073-3046-2025-24-6-106-116
Views:
19
Email this article 